in pathological processes of type 2 diabetes. The aim of the study was to analyze
TP53TG1, LINC00342, MALAT1, H19
Markelov, V.A.,
Korytina, G.F.,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N. Sh. (2024) of lncRNA (
TP53TG1, LINC00342, H19, MALAT1, DNM3OS, and MEG3) and protein-coding (PTEN, TGFB2, FOXO3
Markelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) of lncRNA (
TP53TG1, LINC00342, H19, MALAT1, DNM3OS, and MEG3) and protein-coding (PTEN, TGFB2, FOXO3
Lenkova, Ksenia,
Khusainova, Rita,
Minyazeva, Raushaniya,
Zaripova, Aliya,
Gilyazova, Irina,
Mokrysheva, Natalia,
Minniakhmetov, Ildar (2024) discovered, along with the polymorphic variant rs1042522 in the
TP53 gene, which has been associated